The Muscarinic Acetylcholine Receptor M1 pipeline drugs market research report outlays comprehensive information on the Muscarinic Acetylcholine Receptor M1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Muscarinic Acetylcholine Receptor M1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Respiratory, and Dermatology which include the indications Schizophrenia, Alzheimer’s Disease, Stroke, Systolic Hypertension, Obstructive Sleep Apnea, Snoring, and Axillary Hyperhidrosis. It also reviews key players involved in Muscarinic Acetylcholine Receptor M1 targeted therapeutics development with respective active and dormant or discontinued products.
The Muscarinic Acetylcholine Receptor M1 pipeline targets constitutes close to 29 molecules. Out of which, approximately 28 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 1, 3, 7, 4, 11, and 2 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
Muscarinic Acetylcholine Receptor M1 overview
The M1 muscarinic acetylcholine receptor (mAChR), also known as cholinergic receptor, is a receptor that plays a key role in learning and memory processes. The M1 mAChR is encoded by the CHRM1 gene in humans. It is localized to 11q13. The M1 mAChR is clinically significant in the central nervous system, and it influences neurologic functions.
For a complete picture of Muscarinic Acetylcholine Receptor M1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.